C

Chi V. Dang

Abramson Center for Jewish Life

ORCID: 0000-0002-4031-2522

Publishes on Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, RNA modifications and cancer. 591 papers and 73.5k citations.

PubIndex Score98Top 2%How it's scored

🌟#8 Current Senior Leader in Cancer, Hypoxia, and Metabolism

591Publications

73.5kTotal Citations

#8in Cancer, Hypoxia, and Metabolism

First publication: 1978First senior author: 1983

Cancer, Hypoxia, and Metabolism Epigenetics and DNA Methylation RNA modifications and cancer Ubiquitin and proteasome pathways Cancer-related Molecular Pathways

Top publicationsby citations

Drugging the 'undruggable' cancer targets

Chi V. Dang, Laura Soucek, E. Premkumar Reddy et al.|Nature reviews. Cancer|2017

Cited by 912

Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc

Rebecca C. Osthus, Chi V. Dang|Journal of Biological Chemistry|2000

Cited by 869

c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas

Teh‐Ying Chou, Chi V. Dang|Journal of Biological Chemistry|1995

Cited by 445

Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy

Edgar A. Otto, Corinne Antignac, Toby W. Hurd et al.|Nature Genetics|2010

Cited by 318

Future cancer research priorities in the USA: a Lancet Oncology Commission

Elizabeth M. Jaffee, Richard Sullivan, Mark R. Davis et al.|The Lancet Oncology|2017

Cited by 209